ARS Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.66-$18.90 |
Market Cap | $1.2B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $142.7M |
Revenue Growth (YoY) | 1,471.6% |
Gross Profit (12 Mos) | $114.8M |
Diluted EPS | -$0.81 |
News
See moreYahoo Finance • 13 days ago
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
Yahoo Finance • 2 months ago
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 2 months ago
ARS Pharmaceuticals targets renewed growth in 2026 as neffy adoption accelerates and new global launches begin
Yahoo Finance • 2 months ago
ARS Pharmaceuticals GAAP EPS of -$0.52 misses by $0.05, revenue of $32.5M beats by $3.82M
About
CEO | Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL |
Address | 11682 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 162 |
